Docetaxel versus epirubicin combined with cisplatin, leucovorin and fluorouracil for advanced gastric carcinoma as first line therapy: a randomized clinical trial

doi:10.3969/j.issn.1009-0460.2010.06.012

Home>Articles>Docetaxel versus epirubicin combined with cisplatin, leucovorin and fluorouracil for advanced gastric carcinoma as first line therapy: a randomized clinical trial

DOI: 10.3969/j.issn.1009-0460.2010.06.012

Docetaxel versus epirubicin combined with cisplatin, leucovorin and fluorouracil for advanced gastric carcinoma as first line therapy: a randomized clinical trial

Machine-generated Keywords：

Publication Date：2010-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 529-533 )

CHINESE CLINICAL ONCOLOGY

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2010,15(6)